This inventor holds 1 USPTO granted patent. Top assignee: Echelon Biosciences Incorporated. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of Paul O Neilsen
Introduction
Paul O Neilsen is a notable inventor based in Draper, UT (US). He has made significant contributions to the field of lipid assays, particularly in the detection of cancer cells. His work is characterized by a strong focus on the interaction between proteins and lipids, which has important implications for medical diagnostics.
Latest Patents
One of Paul O Neilsen's key patents is titled "Assaying apparatus, kit, and method for lipids and associated enzymes." This patent describes a lipid assay method, kit, and apparatus that involves exposing a protein with a lipid recognition motif to a solution containing a competing lipid. The method determines the presence of a target lipid, which has a stronger affinity for the lipid recognition motif than the competing lipid. The lipid recognition motif is preferably a pleckstrin homology (PH) domain, with the target lipid being a phosphoinositide. This assay can serve as a cancer screening method, where the detection of specific levels of a PI(3,4,5)P target lipid indicates the presence of cancer cells. Paul O Neilsen holds 1 patent related to this innovative technology.
Career Highlights
Paul O Neilsen is associated with Echelon Biosciences Incorporated, where he continues to develop and refine his inventions. His work at Echelon has positioned him as a key player in the field of lipid research and diagnostics.
Collaborations
Throughout his career, Paul has collaborated with notable colleagues, including Beth E Drees and Glenn D Prestwich. These collaborations have further enhanced the impact of his work in the scientific community.
Conclusion
Paul O Neilsen's innovative contributions to lipid assay technology demonstrate his commitment to advancing medical diagnostics. His work not only highlights the importance of lipid interactions but also opens new avenues for cancer detection.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile